Highlights of the Annual Scientific Meeting of the Society of Skeletal Radiology (SSR) 2018, Austin,Texas, USA

Skeletal Radiology -     

The 33rd report on survey of the adverse reaction to radiopharmaceuticals (the 36th Survey in 2010)

This survey was performed in order to investigate the incidence of adverse reactions to radiopharmaceuticals in FY2010 in Japan. It was based on responses to questionnaires sent to nuclear medicine institutions. The reply was obtained from 961 institutions among 1,259 to which the questionnaire had been sent. Twenty-two cases of adverse reactions were reported. A total of 1,046,243 radiopharmaceutical administrations was reported. The incidence of adverse reactions per 100,000 cases was 2.1. One case of defect products was reported, and the incidence of defect products per 100,000 cases was 0.1.     

第89届北美放射学会收录我国(大陆)论文及展板评析

北美放射学会 (RadiologicalSocietyofNorthAmeri ca,RSNA)是由美国和加拿大两国于 1 91 5年发起成立的地区性放射学术团体 ,当初正值伦琴射线发现近 2 0年 ,遂定名为西部伦琴学会 (WesternRoentgenSociety) ,1 9 1 9年改为现名。RSNA年会是国际上历史悠久、会员众多、科学水平     

The 27th Report on Survey of the Adverse Reaction to Radiopharmaceuticals (the 30th survey in 2004)

This survey was performed in order to investigate the incidence of adverse reactions to radiopharmaceuticals and defect products in FY2004 in Japan. It was based on responses to questionnaires sent to nuclear medicine institutions. The reply was obtained from 968 institutions among 1,220 to which the questionnaire had been sent. Sixteen cases of adverse reactions were reported. A total of 1,277,906 radiopharmaceutical administrations was reported. The incidence of adverse reactions per 100,000 cases was 1.3. Eight cases of defect products were reported, and the incidence of defect products per 100,000 cases was 0.6.     

The 28th report on survey of the adverse reaction to radiopharmaceuticals (the 31st survey in 2005)

This survey was performed in order to investigate the incidence of adverse reactions to radiopharmaceuticals in FY2005 in Japan. It was based on responses to questionnaires sent to nuclear medicine institutions. The reply was obtained from 1,007 institutions among 1,243 to which the questionnaire had been sent. Nineteen cases of adverse reactions were reported. A total of 1,264,098 radiopharmaceutical administrations was reported. The incidence of adverse reactions per 100,000 cases was 1.5. Three cases of defect products were reported, and the incidence of defect products per 100,000 cases was 0.2.